China Universal Asset Management Company’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$84.3K	Sell	9,052 -258	-3%	-$2.25K	0.01%	423
2025 Q4	$69.8K	Buy	9,310 +1,124	+14%	+$11.4K	0.01%	434
2025 Q3	$71.1K	Sell	8,186 -1,118	-12%	-$6.68K	0.01%	410
2025 Q2	$34.5K	Buy	9,304 +17	+0.2%	+$60	﹤0.01%	439
2025 Q1	$30K	Sell	9,287 -515	-5%	-$2.43K	﹤0.01%	446
2024 Q4	$54.6K	Sell	9,802 -193	-2%	-$1.51K	0.01%	447
2024 Q3	$108K	Buy	9,995 +3,922	+65%	+$65.1K	0.01%	352
2024 Q2	$127K	Sell	6,073 -3,506	-37%	-$88K	0.02%	283
2024 Q1	$305K	Buy	9,579 +4,628	+93%	+$118K	0.04%	242
2023 Q4	$100K	Buy	4,951 +3,873	+359%	+$51K	0.02%	277
2023 Q3	$13.7K	Buy	1,078 +529	+96%	+$8.85K	﹤0.01%	325
2023 Q2	$9.92K	Buy	549 +110	+25%	+$2.02K	﹤0.01%	319
2023 Q1	$7.55K	Buy	439 +110	+33%	+$2.14K	﹤0.01%	329
2022 Q4	$7.31K	Buy	329 +26	+9%	+$402	﹤0.01%	255
2022 Q3	$2K	Buy	+303	New	+$2.74K	﹤0.01%	348